BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15609303)

  • 1. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.
    Chen Q; Chao R; Chen H; Hou X; Yan H; Zhou S; Peng W; Xu A
    Int J Cancer; 2005 May; 114(5):675-82. PubMed ID: 15609303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, acute toxicities, and antitumor effects of novel 9-substituted beta-carboline derivatives.
    Cao R; Chen Q; Hou X; Chen H; Guan H; Ma Y; Peng W; Xu A
    Bioorg Med Chem; 2004 Sep; 12(17):4613-23. PubMed ID: 15358288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
    Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
    J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of alkaloids isolated from Peganum harmala seeds.
    Lamchouri F; Zemzami M; Jossang A; Abdellatif A; Israili ZH; Lyoussi B
    Pak J Pharm Sci; 2013 Jul; 26(4):699-706. PubMed ID: 23811445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
    Cao R; Fan W; Guo L; Ma Q; Zhang G; Li J; Chen X; Ren Z; Qiu L
    Eur J Med Chem; 2013 Feb; 60():135-43. PubMed ID: 23291116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells.
    Huang Y; Hager ER; Phillips DL; Dunn VR; Hacker A; Frydman B; Kink JA; Valasinas AL; Reddy VK; Marton LJ; Casero RA; Davidson NE
    Clin Cancer Res; 2003 Jul; 9(7):2769-77. PubMed ID: 12855657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel harmine derivatives for tumor targeted therapy.
    Oncotarget; ; . PubMed ID: 25940702
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.